Back to Search Start Over

Incremental diagnostic value of post-exercise lung congestion in heart failure with preserved ejection fraction.

Authors :
Kagami K
Obokata M
Harada T
Sorimachi H
Yuasa N
Saito Y
Kato T
Wada N
Adachi T
Ishii H
Source :
European heart journal. Cardiovascular Imaging [Eur Heart J Cardiovasc Imaging] 2023 Apr 24; Vol. 24 (5), pp. 553-561.
Publication Year :
2023

Abstract

Aims: Lung ultrasound (LUS) may unmask occult heart failure with preserved ejection fraction (HFpEF) by demonstrating an increase in extravascular lung water (EVLW) during exercise. Here, we sought to examine the dynamic changes in ultrasound B-lines during exercise to identify the optimal timeframe for HFpEF diagnosis.<br />Methods and Results: Patients with HFpEF (n = 134) and those without HF (controls, n = 121) underwent a combination of exercise stress echocardiography and LUS with simultaneous expired gas analysis to identify exercise EVLW. Exercise EVLW was defined by B-lines that were newly developed or increased during exercise. The E/e' ratio peaked during maximal exercise and immediately decreased during the recovery period in patients with HFpEF. Exercise EVLW was most prominent during the recovery period in patients with HFpEF, while its prevalence did not increase from peak exercise to the recovery period in controls. Exercise EVLW was associated with a higher E/e' ratio and pulmonary artery pressure, lower right ventricular systolic function, and elevated minute ventilation to carbon dioxide production (VE vs. VCO2) slope during peak exercise. Increases in B-lines from rest to the recovery period provided an incremental diagnostic value to identify HFpEF over the H2FPEF score and resting left atrial reservoir strain.<br />Conclusion: Exercise EVLW was most prominent early during the recovery period; this may be the optimal timeframe for imaging ultrasound B-lines. Exercise stress echocardiography with assessments of recovery EVLW may enhance the diagnosis of HFpEF.<br />Competing Interests: Conflict of interest: M.O. received speaker honoraria from Novartis, Otsuka Pharmaceutical, Boehringer-Ingelheim, and Bayer.<br /> (© The Author(s) 2023. Published by Oxford University Press on behalf of the European Society of Cardiology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)

Details

Language :
English
ISSN :
2047-2412
Volume :
24
Issue :
5
Database :
MEDLINE
Journal :
European heart journal. Cardiovascular Imaging
Publication Type :
Academic Journal
Accession number :
36691846
Full Text :
https://doi.org/10.1093/ehjci/jead007